youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,67 US$
arrow_downward
-8,87%(-0,26) 1D
2,70 US$
arrow_upward
+1,12% (+0,030)bedtimeAfter hours
Closed: 30 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,89 US$
High
2,92 US$
Low
2,60 US$
Mkt. cap
410,06 მლნ.
Avg. vol.
2,97 მლნ.
Volume
2,91 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
Open
2,89 US$
High
2,92 US$
Low
2,60 US$
Mkt. cap
410,06 მლნ.
Avg. vol.
2,97 მლნ.
Volume
2,91 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
News stories
From web sources and news partners
Substack
·
46 წუთის წინ
The Macro Technical Levels Breached Across The Board: NVDA, INTEL and NASDAQ
Yahoo Finance
·
59 წუთის წინ
3 Underowned S&P 500 Stocks as Investors Rotate Beyond AI
The Globe and Mail
·
1 საათის წინ
3 Unstoppable S&P 500 Stocks to Buy in November
CNBC
·
7 საათის წინ
Anthropic's path to the Nasdaq just got a lot bumpier
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc